Halozyme Therapeutics Inc. (HALO)

$ 71.82
   
  • Change Today:
    $0.21
  • 52 Week High: $72.09
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,434,543
  • Market Cap: $10,436m
  • RiskGrade: 189
  • Beta: 0.14

Latest ShareCast News

Evotec surges on Halozyme takeover interest

By Michele Maatouk

Date: Friday 15 Nov 2024

(Sharecast News) - Evotec surged on Friday after Halozyme Therapeutics confirmed it had submitted a non-binding proposal to buy the German biotech for €11.00 per share in cash, or about €2bn.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HALO Market Data

Currency US Dollars
Share Price $ 71.82
Change Today $ 0.21
% Change 0.29 %
52 Week High $72.09
52 Week Low $42.57
Volume 2,434,543
Shares Issued 145.30m
Market Cap $10,436m
Beta 0.14
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
16:00 204,078 @ $71.82
15:59 100 @ $71.85
15:59 162 @ $71.85
15:59 100 @ $71.84
15:59 100 @ $71.83

Top of Page